abstract |
The present invention relates to a compound used as an NTRK inhibitor and an application thereof. Specifically, the present invention relates to a compound as shown in formula I or a stereoisomer or optical isomer, pharmaceutically acceptable salt, prodrug, or solvate thereof, and also relates to a pharmaceutical composition of the compound and using the compound as an NTRK inhibitor, and a use of the compound in preparation of a drug for preventing and/or treating an NTRK-related disease. |